Description
Dafraclave 228 mg Suspension 70 ml combines amoxicillin 200 mg and clavulanic acid 28 mg per 5 ml, offering broad-spectrum antibiotic coverage against both common and resistant bacterial infections. This formulation enhances treatment efficacy by overcoming beta-lactamase–producing organisms.
Indications:
-
Acute bacterial sinusitis, otitis media, and pharyngitis
-
Community-acquired pneumonia and bronchitis
-
Skin and soft tissue infections
-
Urinary tract infections
Dosage:
Shake well before use. The typical dose is 5 ml every 8 hours (three times daily), or as prescribed by a healthcare professional. Finish the full course even if symptoms improve.
Key Benefits:
-
Effective dual-action mechanism: amoxicillin targets the bacteria, while clavulanic acid inhibits resistance mechanisms
-
Oral suspension ideal for children or individuals with swallowing difficulties
-
Pleasant taste to improve compliance
Precautions:
Use with caution in individuals with a history of penicillin allergy or liver and kidney conditions. Common side effects may include diarrhea, nausea, or rashes. If severe symptoms occur, discontinue use and consult a physician.
Storage:
Refrigerate after opening and discard any unused portion after 10–14 days. Keep out of reach of children.
Reviews
There are no reviews yet.